Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network... Show more
Cypherpunk Technologies is building a rare, vertically integrated franchise around Zcash, a privacy-preserving cryptocurrency that uses zero-knowledge cryptography (a method of verifying transactions without revealing sender, receiver, or amount). The company's mission—advancing technologies that guarantee privacy on the internet—is pursued through two pillars: accumulating ZEC on its balance sheet and investing in or building privacy-focused infrastructure such as the ZODL wallet.
Its competitive positioning is distinctive because there are few publicly traded vehicles offering dedicated Zcash exposure. By combining a treasury (323,394 ZEC as of August 2026, or roughly 1.92% of circulating supply) with a mining fleet representing about 18% of the network's hashrate, Cypherpunk effectively spans both ends of the Zcash value chain—holding the asset and producing it. This alignment is meant to reinforce network security while making the company's own holdings more valuable, a flywheel management has repeatedly emphasized.
At the same time, the company retains a life-sciences arm that was its original identity. Sirexatamab, a monoclonal antibody targeting the DKK1 protein, is advancing toward late-stage oncology development, while FL-501 remains earlier-stage. This creates optionality but also introduces execution complexity for a company with a very small employee base. The medium-term story, however, is firmly anchored in the digital asset strategy rather than the legacy drug pipeline.
Several developments could meaningfully shift investor sentiment in the quarters ahead:
CYPH's trajectory is inseparable from the digital asset cycle. Liquidity conditions, interest-rate policy, and risk appetite broadly influence cryptocurrency prices, and ZEC's relatively small market capitalization amplifies these moves. Inflation trends and the U.S. dollar's strength also feed into demand for alternative stores of value and privacy-oriented assets.
Regulatory climate is a pivotal swing factor. Privacy coins have historically faced scrutiny from regulators and exchanges concerned about anti-money-laundering compliance. Clarity—or renewed restrictions—on privacy-preserving assets could directly affect ZEC's tradability, liquidity, and price, with immediate knock-on effects for Cypherpunk's treasury valuation and mining economics.
Technological adoption matters too. Demand for privacy-enhancing technologies and shielded transactions influences Zcash's utility and long-term value. Meanwhile, energy costs and network difficulty govern mining profitability, even though management argues Zcash mining currently out-earns Bitcoin mining and AI data-center colocation at today's prices. Those economics can shift quickly if hashrate rises or token prices fall.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For a volatile, catalyst-driven name such as CYPH, tools that structure short-term directional signals can complement fundamental analysis. Explore the Trend Prediction Engine to see how AI-driven insights may fit your research process.
Looking into 2026 and beyond, several structural themes will define Cypherpunk's evolution. The first is whether it can convert its Zcash concentration into a durable operating business. Mining adds a recurring flow of ZEC that can fund future accumulation, privacy-technology investments, and overhead—reducing reliance on equity issuance over time if token economics remain favorable.
Margin sustainability and cost structure will hinge on power agreements, mining efficiency, and network difficulty. Management has emphasized debt-free ownership of the fleet and locked-in low power costs, but profitability remains sensitive to ZEC price, which is the single largest driver of both revenue and treasury value.
A second theme is ecosystem consolidation. As the largest corporate ZEC holder and miner, Cypherpunk is positioning itself as a bridge between miners, developers, and users. Success here could strengthen Zcash's network security and adoption, reinforcing the value of its own holdings; setbacks could concentrate risk in a single, thinly traded asset.
Competitive threats include the emergence of rival treasury vehicles or mining operators, as well as broader shifts toward regulated, privacy-lite digital assets. Regulatory developments—both in the U.S. and internationally—remain the most significant wildcard for the entire privacy-focused sector.
Finally, the legacy biotech pipeline offers optionality rather than near-term revenue. Capital allocation choices between digital assets and clinical development will signal management's long-term priorities. With limited analyst coverage, investors will rely heavily on disclosures around treasury composition, mining output, and strategic investments to gauge whether the company's ambitious Zcash-centric vision is translating into sustainable value.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLU | 43.43 | 0.29 | +0.67% |
| State Street Utilities Select Sector SPDR ETF (XLU) | |||
| VSDA | 60.47 | 0.11 | +0.18% |
| VictoryShares Dividend Accelerator ETF (VSDA) | |||
| EFAD | 45.82 | 0.03 | +0.07% |
| ProShares MSCI EAFE Dividend Growers ETF (EFAD) | |||
| TUSI | 25.19 | -0.03 | -0.14% |
| Touchstone Ultra Short Income ETF (TUSI) | |||
| PCFI | 22.17 | -0.13 | -0.58% |
| POLEN FLOATING RATE INCOME ETF | |||
A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.
| Ticker / NAME | Correlation To CYPH | 1D Price Change % | ||
|---|---|---|---|---|
| CYPH | 100% | -9.97% | ||
| INKT - CYPH | 42% Loosely correlated | -1.50% | ||
| AXON - CYPH | 40% Loosely correlated | -2.35% | ||
| SABS - CYPH | 36% Loosely correlated | +3.72% | ||
| AMRN - CYPH | 35% Loosely correlated | -4.91% | ||
| DFDV - CYPH | 34% Loosely correlated | -14.29% | ||
More | ||||
| Ticker / NAME | Correlation To CYPH | 1D Price Change % |
|---|---|---|
| CYPH | 100% | -9.97% |
| Investment Managers industry (136 stocks) | 22% Poorly correlated | +0.57% |
a company, which engages in clinical stage immuno-oncology
Industry InvestmentManagers
The 10-day RSI Oscillator for CYPH moved out of overbought territory on September 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 23 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 45 cases where CYPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for CYPH turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 32 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CYPH entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on CYPH as a result. In 66 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
Following a +5.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYPH advanced for three days, in 215 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CYPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.305) is normal, around the industry mean (2.410). P/E Ratio (4.656) is within average values for comparable stocks, (-3.016). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.272) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.